Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Cash from Financing Activities (2016 - 2026)

Healthequity (HQY) has 13 years of Cash from Financing Activities data on record, last reported at -$122.4 million in Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 48.51% year-over-year to -$122.4 million; the TTM value through Oct 2025 reached -$375.6 million, down 350.23%, while the annual FY2025 figure was $57.6 million, 222.38% up from the prior year.
  • Cash from Financing Activities reached -$122.4 million in Q4 2025 per HQY's latest filing, down from -$108.1 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $444.9 million in Q2 2021 and bottomed at -$122.4 million in Q4 2025.
  • Average Cash from Financing Activities over 5 years is $5.2 million, with a median of -$2.6 million recorded in 2022.
  • Peak YoY movement for Cash from Financing Activities: tumbled 8112.0% in 2021, then skyrocketed 8295.68% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at -$47.2 million in 2021, then skyrocketed by 97.68% to -$1.1 million in 2022, then soared by 285.21% to $2.0 million in 2023, then plummeted by 4163.86% to -$82.4 million in 2024, then plummeted by 48.51% to -$122.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were -$122.4 million in Q4 2025, -$108.1 million in Q3 2025, and -$56.6 million in Q2 2025.